Results 81 to 90 of about 924,361 (397)

The life expectancy of patients with metabolic syndrome after weight loss: study protocol for a randomized clinical trial (LIFEXPE-RT)

open access: yesTrials, 2019
Background To date, surgeons and physicians have found positive results treating metabolic syndrome with surgical and non-surgical weight loss therapies.
Oral Ospanov   +3 more
doaj   +1 more source

Optimal Cutoff Size of Large Borrmann Type III Gastric Cancer: Is 8 cm Accurate in Predicting Survival and Incidence of Peritoneal Metastasis?

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
ABSTRACT Background Large type III gastric cancer (GC) ≥ 8 cm has conventionally been categorized with type IV GC in Japan, leading to alternative treatment strategies such as neoadjuvant chemotherapy and staging laparoscopy (SL). However, whether 8 cm is the correct cutoff remains unclear.
Yutaka Sugita   +8 more
wiley   +1 more source

Gastrojejunostomy junction perforation resulting from Dobhoff tube insertion in a patient with a history of Roux-en-Y surgery: a case report

open access: yesJournal of Medical Case Reports
Background Gastrojejunostomy junction perforation is a rare yet critical complication associated with enteral tube placement, presenting unique challenges in patients with a history of Roux-en-Y gastric bypass surgery.
Monty Khela   +5 more
doaj   +1 more source

Measurement of hepatic insulin sensitivity early after the bypass of the proximal small bowel in humans

open access: yesObesity Science & Practice, 2017
Summary Objective Unlike gastric banding or sleeve gastrectomy procedures, intestinal bypass procedures, Roux‐en‐Y gastric bypass in particular, lead to rapid improvements in glycaemia early after surgery.
A. D. Miras   +11 more
doaj   +1 more source

Vascular challenges from pancreatoduodenectomy in the setting of coeliac artery stenosis [PDF]

open access: yes, 2017
Coeliac artery stenosis due to median arcuate ligament compression or atherosclerotic disease is a frequently unrecognised challenge to recovery after pancreatoduodenectomy.
Beane, Joal D., Schwarz, Roderich E.
core   +1 more source

Design, Control, and Clinical Applications of Magnetic Actuation Systems: Challenges and Opportunities

open access: yesAdvanced Intelligent Systems, Volume 7, Issue 3, March 2025.
This review aims to provide a broad understanding for interdisciplinary researchers in engineering and clinical applications. It addresses the development and control of magnetic actuation systems (MASs) in clinical surgeries and their revolutionary effects in multiple clinical applications.
Yingxin Huo   +3 more
wiley   +1 more source

Physiologically Based Pharmacokinetic Modeling for Predicting Drug Levels After Bariatric Surgery: Vardenafil Exposure Before vs. After Gastric Sleeve/Bypass

open access: yesBiomolecules
Bariatric surgery involves major changes in the anatomy and physiology of the gastrointestinal tract, which may alter oral drug bioavailability and efficacy. Phosphodiesterase-5 inhibitor (PDE5i) drugs are the first-line treatment of erectile dysfunction,
Daniel Porat   +3 more
doaj   +1 more source

Totally robotic gastric bypass

open access: yesJournal of Visceral Surgery, 2011
Bariatric surgery ensures significant and lasting weight loss in the morbidly obese. Thegoal of weight loss is to reduce the morbidity (diabetes, sleep apnea, arterial hyperten-sion, hyperlipidemia...) and mortality related to morbid obesity. A robotic device can beused solely for the gastrojejunostomy (robotic-assisted bypass) or, more logically, for ...
N. Reibel   +2 more
openaire   +3 more sources

Plastic Surgery After Gastric Bypass Improves Long-Term Quality of Life [PDF]

open access: yes, 2018
Background: Excess skin after massive weight loss impairs patient's health-related quality of life (HRQoL). Therefore, body-contouring surgeries can be proposed.
Balagué, N.   +4 more
core  

Genotype–Phenotype Correlation in TTC7A‐Associated Gastrointestinal Defects and Immunodeficiency Syndrome 1

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Gastrointestinal defects and immunodeficiency syndrome 1 (GIDID1) is a rare autosomal recessive disorder caused by biallelic variants in TTC7A. GIDID1 is characterized by a broad clinical spectrum ranging from very early‐onset inflammatory bowel disease (VEOIBD) to multiple intestinal atresia (MIA) with or without immunological manifestations.
Julia Imhoff   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy